Immunocore Holdings plc
IMCR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001671927
No open-market purchases or sales by Immunocore Holdings plc insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $1.65B in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Immunocore Holdings plc as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 104
- +18 vs. Q3 2022
- Shares held
- 30.3M
- +3.73M (+14.1%) vs. Q3 2022
- Total value
- $1.73B
- +$480.2M (+38.5%) vs. Q3 2022
- New holders
- 31
- 36 more added
- Sold out
- 13
- 26 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMCR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 135 | $1.65B |
| Q1 2026 | 142 | $1.58B |
| Q4 2025 | 149 | $1.79B |
| Q3 2025 | 133 | $1.79B |
| Q2 2025 | 134 | $1.50B |
| Q1 2025 | 117 | $1.40B |
| Q4 2024 | 116 | $1.34B |
| Q3 2024 | 130 | $1.41B |
| Q2 2024 | 139 | $1.46B |
| Q1 2024 | 149 | $2.68B |
| Q4 2023 | 133 | $2.56B |
| Q3 2023 | 125 | $1.92B |
| Q2 2023 | 120 | $2.12B |
| Q1 2023 | 109 | $1.61B |
| Q4 2022 | 104 | $1.73B |
| Q3 2022 | 86 | $1.25B |
| Q2 2022 | 66 | $784.5M |
| Q1 2022 | 57 | $590.1M |
| Q4 2021 | 49 | $642.4M |
| Q3 2021 | 47 | $617.4M |
| Q2 2021 | 45 | $561.1M |
| Q1 2021 | 41 | $597.8M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Immunocore Holdings plc; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wellington Management Group LLP | 2,152,966 | $122.9M | 0.02% | +1,478,233+219.1% | Added |
| Baker Bros. Advisors LP | 2,520,731 | $143.9M | 0.86% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 3,321,066 | $189.5M | 4.56% | −172,677−4.9% | Reduced |
| RTW Investments, LP | 5,559,322 | $317.3M | 6.48% | +1,107,839+24.9% | Added |
| Rathbone Brothers plc | 0 | $0 | 0.00% | −190,015−100.0% | Sold out |
| VR Adviser, LLC | 0 | $0 | 0.00% | −94,605−100.0% | Sold out |
| Great Point Partners LLC | 0 | $0 | 0.00% | −78,527−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −34,697−100.0% | Sold out |
| ETF Managers Group, LLC | 0 | $0 | 0.00% | −12,944−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −8,900−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −8,202−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −8,186−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −4,892−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −3,470−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −472−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Cullen/Frost Bankers, Inc. | 0 | $0 | 0.00% | −11−100.0% | Sold out |